万孚生物
(300482)
| 流通市值：78.66亿 | | | 总市值：85.61亿 |
| 流通股本：4.30亿 | | | 总股本：4.68亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 371,229,718.52 | 462,528,126.58 | 205,184,946.58 | 343,670,598.96 |
| 结算备付金 | - | - | 0 | - |
| 拆出资金 | - | - | 0 | - |
| 交易性金融资产 | 1,599,852,582.84 | 1,264,492,022.17 | 1,406,465,140.66 | 1,261,537,727.88 |
| 衍生金融资产 | - | - | 0 | - |
| 应收票据及应收账款 | 777,334,094.55 | 788,368,441.69 | 1,075,823,510.7 | 1,223,778,055.62 |
| 其中：应收票据 | 6,674,678.47 | 14,179,690.99 | 30,205,140.02 | 34,202,155.16 |
| 应收账款 | 770,659,416.08 | 774,188,750.7 | 1,045,618,370.68 | 1,189,575,900.46 |
| 应收款项融资 | 1,950,264.67 | 3,507,735.58 | 0 | - |
| 预付款项 | 10,839,935.38 | 10,457,519 | 16,527,839.56 | 17,129,899.46 |
| 应收保费 | - | - | 0 | - |
| 应收分保账款 | - | - | 0 | - |
| 应收分保合同准备金 | - | - | 0 | - |
| 其他应收款合计 | 47,815,179.59 | 44,129,345.19 | 87,200,795.28 | 78,780,919.11 |
| 其中:应收利息 | - | - | 0 | - |
| 应收股利 | - | - | 0 | - |
| 买入返售金融资产 | - | - | 0 | - |
| 存货 | 274,034,841.51 | 280,584,203.09 | 346,489,631.92 | 347,358,937.24 |
| 合同资产 | - | - | 0 | - |
| 一年内到期的非流动资产 | 245,888,568.22 | 321,359,444.6 | 0 | - |
| 其他流动资产 | 127,939,122.29 | 125,878,390.34 | 137,575,046.47 | 110,806,277 |
| 流动资产合计 | 3,456,884,307.57 | 3,301,305,228.24 | 3,275,266,911.17 | 3,383,062,415.27 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | - | - | 0 | - |
| 债权投资 | 768,924,409.44 | 764,573,882.06 | 885,058,163.65 | 1,036,543,589.68 |
| 其他债权投资 | - | - | 0 | - |
| 长期应收款 | 6,696,550 | 6,696,550 | 0 | - |
| 长期股权投资 | 487,895,209.99 | 459,435,165.42 | 406,175,169 | 407,858,152.95 |
| 其他权益工具投资 | 91,990,000 | 91,990,000 | 111,997,538.21 | 95,423,435.76 |
| 其他非流动金融资产 | - | - | 0 | - |
| 投资性房地产 | - | - | 0 | - |
| 固定资产 | 1,391,159,799.47 | 1,424,958,500.15 | 1,456,853,768.45 | 1,450,304,177.95 |
| 在建工程 | 17,818,186.25 | 17,245,672.18 | 14,541,830.26 | 9,471,589.56 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | 10,206,269.79 | 11,458,579.26 | 13,340,415.58 | 14,844,980.83 |
| 无形资产 | 243,193,789.35 | 245,693,048.53 | 225,099,561.25 | 224,119,955.96 |
| 开发支出 | 27,202,635.9 | 30,232,280.95 | 55,232,653.87 | 63,693,557.36 |
| 商誉 | 108,966,887.72 | 108,966,887.72 | 111,418,791.83 | 111,418,791.83 |
| 长期待摊费用 | 10,274,279.82 | 10,784,057.54 | 11,356,374.15 | 13,559,297.52 |
| 递延所得税资产 | 97,585,835.91 | 112,689,643.27 | 71,227,275.42 | 74,307,084.48 |
| 其他非流动资产 | 15,369,971.06 | 15,647,722.63 | 14,945,877.66 | 15,421,693.85 |
| 非流动资产合计 | 3,277,283,824.7 | 3,300,371,989.71 | 3,377,247,419.33 | 3,516,966,307.73 |
| 资产总计 | 6,734,168,132.27 | 6,601,677,217.95 | 6,652,514,330.5 | 6,900,028,723 |
| 流动负债: | | | | |
| 短期借款 | 0 | 7,000 | 7,000 | 1,710,000 |
| 向中央银行借款 | - | - | 0 | - |
| 吸收存款及同业存放 | - | - | 0 | - |
| 拆入资金 | - | - | 0 | - |
| 交易性金融负债 | - | - | 0 | - |
| 衍生金融负债 | - | - | 0 | - |
| 应付票据及应付账款 | 258,789,367.8 | 210,809,670.91 | 253,426,744.48 | 271,167,484.7 |
| 其中：应付票据 | 62,139,648.91 | 52,596,084.53 | 0 | - |
| 应付账款 | 196,649,718.89 | 158,213,586.38 | 253,426,744.48 | 271,167,484.7 |
| 预收款项 | - | - | 0 | - |
| 合同负债 | 65,313,046.11 | 75,664,234.02 | 71,778,224.9 | 64,936,695.8 |
| 卖出回购金融资产款 | - | - | 0 | - |
| 应付手续费及佣金 | - | - | 0 | - |
| 应付职工薪酬 | 61,062,841.9 | 74,085,981.85 | 45,094,269.88 | 66,932,529.12 |
| 应交税费 | 19,031,836.67 | 7,635,812.5 | 7,438,010.43 | 12,869,420.05 |
| 其他应付款合计 | 40,522,205.82 | 48,537,738.83 | 31,441,955.76 | 162,217,448.75 |
| 其中:应付利息 | - | - | 0 | - |
| 应付股利 | - | - | 0 | - |
| 应付分保账款 | - | - | 0 | - |
| 保险合同准备金 | - | - | 0 | - |
| 代理买卖证券款 | - | - | 0 | - |
| 代理承销证券款 | - | - | 0 | - |
| 一年内到期的非流动负债 | 599,275,884.5 | 592,381,330.5 | 5,005,520.61 | 5,367,806.95 |
| 其他流动负债 | 28,688,773.88 | 29,753,600.25 | 7,008,427.95 | 6,576,580.48 |
| 流动负债合计 | 1,072,683,956.68 | 1,038,875,368.86 | 421,200,154.01 | 591,777,965.85 |
| 非流动负债: | | | | |
| 长期借款 | - | - | 0 | - |
| 应付债券 | - | 0 | 581,258,213.47 | 584,933,848.87 |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 租赁负债 | 8,206,282.97 | 9,263,807.72 | 10,246,635.68 | 11,289,277.42 |
| 长期应付款 | - | - | 0 | - |
| 长期应付职工薪酬 | - | - | 0 | - |
| 预计负债 | - | - | 0 | - |
| 递延收益 | 43,637,731.79 | 44,536,766.92 | 39,152,065.35 | 42,443,884 |
| 递延所得税负债 | 31,820,008.09 | 35,441,461.27 | 40,174,218.06 | 42,180,259.86 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债合计 | 83,664,022.85 | 89,242,035.91 | 670,831,132.56 | 680,847,270.15 |
| 负债合计 | 1,156,347,979.53 | 1,128,117,404.77 | 1,092,031,286.57 | 1,272,625,236 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 468,085,902 | 468,084,909 | 468,084,798 | 478,628,761 |
| 其他权益工具 | 107,445,018.99 | 107,448,794.26 | 107,449,333.58 | 107,449,513.35 |
| 资本公积 | 1,398,778,304.96 | 1,398,754,522.69 | 1,305,900,909.58 | 1,426,312,246.81 |
| 减:库存股 | 30,093,931.34 | 30,093,931.34 | 275,729 | 135,758,880 |
| 其他综合收益 | -68,127,912.79 | -86,244,784.12 | -128,809,471 | -128,780,612.95 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 261,061,579.09 | 261,061,579.09 | 261,061,579.09 | 261,061,579.09 |
| 一般风险准备 | - | - | 0 | - |
| 未分配利润 | 3,380,014,456.6 | 3,295,614,906.84 | 3,487,043,631.82 | 3,542,502,742.11 |
| 归属于母公司股东权益合计 | 5,517,163,417.51 | 5,414,625,996.42 | 5,500,455,052.07 | 5,551,415,349.41 |
| 少数股东权益 | 60,656,735.23 | 58,933,816.76 | 60,027,991.86 | 75,988,137.59 |
| 股东权益合计 | 5,577,820,152.74 | 5,473,559,813.18 | 5,560,483,043.93 | 5,627,403,487 |
| 负债和股东权益合计 | 6,734,168,132.27 | 6,601,677,217.95 | 6,652,514,330.5 | 6,900,028,723 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-27 | 2025-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |